Skip to main menu | Skip to main content
EN  |  FR

Apobiologix - Our Portfolio


Current Portfolio

Below is a list of Apobiologix' marketed products.
This information is intended for residents of Canada only.

Pipeline Portfolio

We are here for the long term, continuing our investment into a pipeline of biosimilars to ensure patients and HCPs have broad access to affordable medicines.

Apobiologix continues to invest in oncology biosimilars and expanding our portfolio to new therapeutic areas. Our focus remains on an unwavering commitment to transforming access in emerging biosimilar medicines - the same way we did in oncology.

Back to top